Early Alterations in Gene Expression and Cell Morphology in a Mouse Model of Huntington's Disease

Several mouse models for Huntington's disease (HD) have been produced to date. Based on differences in strain, promoter, construct, and number of glutamines, these models have provided a broad spectrum of neurological symptoms, ranging from simple increases in aggressiveness with no signs of neuropathology, to tremors and seizures in absence of degeneration, to neurological symptoms in the presence of gliosis and TUNEL (terminal deoxynucleotidyl transferase‐mediated dUTP nick end‐labeling) positivity, and finally to selective striatal damage associated with electrophysiological and behavioral abnormalities. We decided to analyze the morphology of striatum and hippocampus from a mouse transgenic line obtained by microinjection of exon 1 from the HD gene after introduction of a very high number of CAG repeat units. We found a massive darkening and compacting of striatal and hippocampal neurons in affected mice, associated with a lower degree of more classical apoptotic cell condensation. We then explored whether this morphology could be explained with alterations in gene expression by hybridizing normal and affected total brain RNA to a panel of 588 known mouse cDNAs. We show that some genes are significantly and consistently up‐regulated and that others are down‐regulated in the affected brains. Here we discuss the possible significance of these alterations in neuronal morphology and gene expression.

[1]  P. Rodríguez,et al.  Prothymosin alpha is a chromatin-remodelling protein in mammalian cells. , 1998, The Biochemical journal.

[2]  P. Rodríguez,et al.  Prothymosin α antisense oligonucleotides induce apoptosis in HL-60 cells , 1999, Cell Death and Differentiation.

[3]  D. K. Hawley,et al.  In vitro analysis of a transcription termination site for RNA polymerase II , 1990, Molecular and Cellular Biology.

[4]  Harry T Orr,et al.  Ataxin-1 Nuclear Localization and Aggregation Role in Polyglutamine-Induced Disease in SCA1 Transgenic Mice , 1998, Cell.

[5]  Mark Turmaine,et al.  Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation , 1997, Cell.

[6]  H. Johnston,et al.  A Huntington's disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice. , 1999, Human molecular genetics.

[7]  G. Covelo,et al.  Prothymosin alpha binds histones in vitro and shows activity in nucleosome assembly assay. , 1996, Biochimica et biophysica acta.

[8]  D. Kufe,et al.  Caspase-3-mediated Cleavage of Protein Kinase C θ in Induction of Apoptosis* , 1997, The Journal of Biological Chemistry.

[9]  J C Reed,et al.  Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. , 1999, Science.

[10]  S. Llanos,et al.  The c‐erbAα Protooncogene Induces Apoptosis in Glial Cells via a Protein Kinase C‐ and bcl‐2‐Suppressible Mechanism , 1998, Journal of neurochemistry.

[11]  Claire-Anne Gutekunst,et al.  A YAC Mouse Model for Huntington’s Disease with Full-Length Mutant Huntingtin, Cytoplasmic Toxicity, and Selective Striatal Neurodegeneration , 1999, Neuron.

[12]  P. Rodríguez,et al.  Prothymosin alpha antisense oligonucleotides induce apoptosis in HL-60 cells. , 1999, Cell death and differentiation.

[13]  S. W. Davies,et al.  Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice , 1996, Cell.

[14]  G. McKnight,et al.  Regulation of transcription by cyclic AMP-dependent protein kinase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Li Chen,et al.  Rad23 links DNA repair to the ubiquitin/proteasome pathway , 1998, Nature.

[16]  M. Gurney.  Neuroleukin: Basic Biology and Functional Interaction with Human Immunodeficiency Virus , 1987, Immunological reviews.

[17]  Lisa Garrett,et al.  Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA , 1998, Nature Genetics.

[18]  Zoe Karetsou,et al.  Prothymosin alpha modulates the interaction of histone H1 with chromatin , 1998, Nucleic Acids Res..

[19]  Z. Darżynkiewicz,et al.  Changes in nuclear chromatin related to apoptosis or necrosis induced by the DNA topoisomerase II inhibitor fostriecin in MOLT-4 and HL-60 cells are revealed by altered DNA sensitivity to denaturation. , 1992, Experimental cell research.

[20]  Susan S. Taylor,et al.  Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. , 1999, Molecular cell.

[21]  H. Rosenbauer,et al.  A repeated 18 bp sequence motif in the mouse rDNA spacer mediates binding of a nuclear factor and transcription termination , 1986, Cell.

[22]  G. Längst,et al.  RNA polymerase I transcription on nucleosomal templates: the transcription termination factor TTF‐I induces chromatin remodeling and relieves transcriptional repression , 1997, The EMBO journal.

[23]  Y. Yazaki,et al.  Temporal and spatial distribution of DNA topoisomerase II alters during proliferation, differentiation, and apoptosis in HL-60 cells. , 1998, Blood.

[24]  K. Moulder,et al.  Generation of Neuronal Intranuclear Inclusions by Polyglutamine-GFP: Analysis of Inclusion Clearance and Toxicity as a Function of Polyglutamine Length , 1999, The Journal of Neuroscience.

[25]  T. L. Collins,et al.  Direct interaction between protein kinase C theta (PKC theta) and 14-3-3 tau in T cells: 14-3-3 overexpression results in inhibition of PKC theta translocation and function , 1996, Molecular and cellular biology.

[26]  W. T. Beck,et al.  Merbarone, a catalytic inhibitor of DNA topoisomerase II, induces apoptosis in CEM cells through activation of ICE/CED-3-like protease. , 1999, Molecular pharmacology.

[27]  O. Gandrillon,et al.  c-erbA alpha/T3R and RARs control commitment of hematopoietic self-renewing progenitor cells to apoptosis or differentiation and are antagonized by the v-erbA oncogene. , 1994, Oncogene.

[28]  M. Gurney,et al.  Molecular cloning and expression of neuroleukin, a neurotrophic factor for spinal and sensory neurons. , 1986, Science.

[29]  C. Davis,et al.  BIGEL analysis of gene expression in HL60 cells exposed to X rays or 60 Hz magnetic fields. , 1998, Radiation research.

[30]  S. Kondo,et al.  Induction of Thymocyte Apoptosis by Ca2+-independent Protein Kinase C (nPKC) Activation and Its Regulation by Calcineurin Activation* , 1998, The Journal of Biological Chemistry.

[31]  D. Borchelt,et al.  Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. , 1999, Human molecular genetics.

[32]  Y. Liu.  Expression of Polyglutamine-expanded Huntingtin Activates the SEK1-JNK Pathway and Induces Apoptosis in a Hippocampal Neuronal Cell Line* , 1998, The Journal of Biological Chemistry.

[33]  R. Idzerda,et al.  PKA isoforms, neural pathways, and behaviour: making the connection , 1997, Current Opinion in Neurobiology.

[34]  R. Idzerda,et al.  Role of Regulatory Subunits and Protein Kinase Inhibitor (PKI) in Determining Nuclear Localization and Activity of the Catalytic Subunit of Protein Kinase A* , 1999, The Journal of Biological Chemistry.

[35]  Y. Mizrachi.  Neurotrophic activity of monomeric glucophosphoisomerase was blocked by human immunodeficiency virus (HIV‐1) and peptides from HIV‐1 envelope glycoprotein , 1989, Journal of neuroscience research.